957 related articles for article (PubMed ID: 12444097)
21. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
Garcia-Higuera I; Taniguchi T; Ganesan S; Meyn MS; Timmers C; Hejna J; Grompe M; D'Andrea AD
Mol Cell; 2001 Feb; 7(2):249-62. PubMed ID: 11239454
[TBL] [Abstract][Full Text] [Related]
22. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast 2-hybrid system.
Reuter T; Herterich S; Bernhard O; Hoehn H; Gross HJ
Blood; 2000 Jan; 95(2):719-20. PubMed ID: 10627486
[TBL] [Abstract][Full Text] [Related]
23. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport.
Reuter TY; Medhurst AL; Waisfisz Q; Zhi Y; Herterich S; Hoehn H; Gross HJ; Joenje H; Hoatlin ME; Mathew CG; Huber PA
Exp Cell Res; 2003 Oct; 289(2):211-21. PubMed ID: 14499622
[TBL] [Abstract][Full Text] [Related]
24. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea AD
Blood; 2000 Sep; 96(5):1625-32. PubMed ID: 10961856
[TBL] [Abstract][Full Text] [Related]
25. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
[TBL] [Abstract][Full Text] [Related]
26. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
Garcia-Higuera I; Kuang Y; Näf D; Wasik J; D'Andrea AD
Mol Cell Biol; 1999 Jul; 19(7):4866-73. PubMed ID: 10373536
[TBL] [Abstract][Full Text] [Related]
27. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
28. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
29. Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
Jeong E; Lee SG; Kim HS; Yang J; Shin J; Kim Y; Kim J; Schärer OD; Kim Y; Yeo JE; Kim HM; Cho Y
Nucleic Acids Res; 2020 Apr; 48(6):3328-3342. PubMed ID: 32002546
[TBL] [Abstract][Full Text] [Related]
30. Evidence for subcomplexes in the Fanconi anemia pathway.
Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
[TBL] [Abstract][Full Text] [Related]
31. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.
Garcia-Higuera I; Kuang Y; Denham J; D'Andrea AD
Blood; 2000 Nov; 96(9):3224-30. PubMed ID: 11050007
[TBL] [Abstract][Full Text] [Related]
32. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
Li ZY; Zou YF; Deng YB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
[TBL] [Abstract][Full Text] [Related]
33. The Fanconi anemia core complex associates with chromatin during S phase.
Mi J; Kupfer GM
Blood; 2005 Jan; 105(2):759-66. PubMed ID: 15256425
[TBL] [Abstract][Full Text] [Related]
34. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
[TBL] [Abstract][Full Text] [Related]
35. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.
Waisfisz Q; de Winter JP; Kruyt FA; de Groot J; van der Weel L; Dijkmans LM; Zhi Y; Arwert F; Scheper RJ; Youssoufian H; Hoatlin ME; Joenje H
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10320-5. PubMed ID: 10468606
[TBL] [Abstract][Full Text] [Related]
36. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
37. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
38. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
Gordon SM; Alon N; Buchwald M
J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
[TBL] [Abstract][Full Text] [Related]
39. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
[TBL] [Abstract][Full Text] [Related]
40. AMP-activated protein kinase is involved in the activation of the Fanconi anemia/BRCA pathway in response to DNA interstrand crosslinks.
Chun MJ; Kim S; Hwang SK; Kim BS; Kim HG; Choi HI; Kim JH; Goh SH; Lee CH
Oncotarget; 2016 Aug; 7(33):53642-53653. PubMed ID: 27449087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
